Navigation Links
Amgen's Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94
Date:10/22/2013

THOUSAND OAKS, Calif., Oct. 22, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced results for the third quarter of 2013.  Key financial results for the quarter include:

  • Total revenues increased 10 percent to $4,748 million, with 11 percent product sales growth driven by strong performance across the portfolio, particularly from Neulasta® (pegfilgrastim), Enbrel® (etanercept), Prolia® (denosumab) and XGEVA® (denosumab). Product sales included a $155 million order for NEUPOGEN® (filgrastim) from the U.S. government.
  • Adjusted EPS grew 16 percent to $1.94, with higher revenues and a lower tax rate partially offset by increased Research & Development (R&D) investment. Adjusted net income increased 13 percent to $1,481 million.
  • GAAP EPS were $1.79 compared to $1.41 and GAAP net income was $1,368 million compared to $1,107 million.
  • The Company generated approximately $1.6 billion of free cash flow.
  • "We delivered excellent operating performance this quarter," said Robert A. Bradway, chairman and chief executive officer of Amgen. "We also delivered excellent strategic progress with the acquisition of Onyx Pharmaceuticals in oncology, the opening of our alliances in Japan and China, and the repurchase of our rights to NEUPOGEN and Neulasta in key emerging growth markets around the world."Year-over-Year$Millions, except EPS and percentagesQ3 '13Q3 '12YOY ΔTotal Revenues$ 4,748$ 4,31910%Adjusted Net Income$ 1,481$ 1,31113%Adjusted EPS$ 1.94$ 1.6716%GAAP Net Income$ 1,368$ 1,10724%GAAP EPS$ 1.79$ 1.4127%References in this release to "adjusted" measures, measures presented "on an adjusted basis" or to free cash flow refer to non-GAAP financial measures.  These adjustments and other items are presented on the atta
    '/>"/>

    SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
    2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    3. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
    4. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
    5. Cardica Announces Fiscal 2012 Third Quarter Financial Results
    6. Hill-Rom Announces Third Quarter 2012 Dividend
    7. Cardinal Health Reports Third-Quarter Results
    8. TPI to Host Third Quarter of Fiscal Year 2012 Earnings Conference Call on Tuesday, May 15, 2012 at 9:00 a.m. ET
    9. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
    10. ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
    11. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... , May 22, 2015  Effective staffing of ... brand recognition and success. Research ... study to provide pharmaceutical and biotech marketing managers ... and budget) that are being channeled into marketing ... marketing managers can utilize this report to benchmark ...
    (Date:5/22/2015)... 2015 The Assistance Fund announces the addition ... financial assistance for copay to individuals diagnosed with Melanoma. ... addition of the Melanoma Copay Assistance Program to our ... executive director. "With each additional program we are closer ... where no one is denied access to medications due ...
    (Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
    Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4
    (Date:5/25/2015)... May 25, 2015 Burke Rehabilitation Hospital ... PBDW Architects in New York City, to speak at Burke ... the hospital’s ongoing Legacy Lobby Lecture series, will take place ... White is the great grandson of Stanford White of McKim, ... design of Burke’s campus 100 years ago. , “We are ...
    (Date:5/24/2015)... Kong (PRWEB) May 25, 2015 Pacific Prime has ... three part report looking at the cost of individual international ... Destinations, Article 2 looks at the cost of health insurance in ... , Focusing on, Hong Kong , ... the UAE , the UK ...
    (Date:5/24/2015)... Metamora, Michigan (PRWEB) May 24, 2015 ... for concerns about hair loss. Although it is unclear ... that there are environmental factors such as metabolism, nutritional ... contribute. Since they offer a comprehensive approach to evaluating ... and post-menopausal woman, they can help patients find a ...
    (Date:5/24/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... which will allow them to take pressure measurements in ... bladder function. The doctor usually orders it if they ... overactive bladder (OAB). , Women’s Excellence in ... have problems with unwanted urinary leakage or problems with ...
    (Date:5/24/2015)... May 24, 2015 EnviroLeather™ by ... “InkGard™ Plus” – a classic, rugged leather grain ... allowing difficult stains, including ink, to be easily ... colors suitable for corporate, healthcare, hospitality and education ... with EnviroLeather’s goal of developing products that are ...
    Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2
    ... HealthDay Reporter , THURSDAY, Sept. 15 (HealthDay News) -- The ... year, so seniors need to start looking at their current ... health officials said Thursday. The good news is that ... percent of Medicare recipients who have access to Medicare Advantage, ...
    ... A new study suggests that blocking cancer cells, access ... glioblastoma, the most common and deadly form of brain ... be appropriate for tumors with a hyperactive PI3K signaling ... glioblastomas cases. , Researchers at the Ohio State University ...
    ... Ovarian cancer is a rare but often deadly disease ... It affects one in 70 women and in the past ... found there are symptoms associated with ovarian cancer that can ... best defense is to make use of preventive methods, understand ...
    ... THURSDAY, Sept. 15 (HealthDay News) -- Experts around the world ... against alcohol abuse. A group of international medical ... effects of excess alcohol, and it also urged governments to ... third leading risk factor in preventable and premature disease, affecting ...
    ... 15, 2011 The demand for transparency through publicly available ... for administrative and clinical data for research, and for clinical ... access has a measurable impact on research and policy making. ... Research Chair in Electronic Health Information at the University of ...
    ... 2011) For patients with ovarian cancer and their ... researchers at Moffitt Cancer Center have identified a molecular ... evolution of chemotherapy resistance. They are hopeful that the ... individual patients with ovarian cancer; reversing resistance to chemotherapy ...
    Cached Medicine News:Health News:Enrollment Period for Medicare Starts Early This Year 2Health News:Starving cancer cells of cholesterol might offer a new way to treat brain tumors 2Health News:Early detection is key in the fight against ovarian cancer 2Health News:Early detection is key in the fight against ovarian cancer 3Health News:Doctors Urged to Lead Battle Against Alcohol Abuse 2Health News:New report on creating clinical public use microdata files 2Health News:Moffitt researchers find possible key to preventing chemotherapy resistance in ovarian cancer 2
    ... various plastic primary and secondary tubes in a ... and diameters can be sealed in one run. ... The integration into other PVT Systems (e.g. Sorting ... High Throughput Sorter RSD ProVolume ) is ...
    ... System DS 800 selectively removes closures from various ... barcode towards the rack opening in one run. ... in PVT Systems like Sorting System RS 800 ... RSD ProVolume and Aliquoting System RSD 800A. All ...
    ... offers reagents to detect sequences of ... virus 1, 2 and 3; influenza ... syncytial virus A and B. ... create homebrew tests., *Analyte ...
    ... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
    Medicine Products: